WallStreetZenWallStreetZen
Analyst Ranking
Bottom 11%
#3940 out of 4414 analysts
Average Return
-7.45%
Win Rate
35%16 out of 46
Risk vs Reward
Poor
Good

Paul Matteis's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Gw Pharmaceuticals PLCGWPH
+64.79%$98.51$162.33
2017-10-01 -
2018-10-02
Buy
Neurocrine Biosciences IncNBIX
+59.15%$72.78$115.83
2017-11-01 -
2018-11-02
Buy
Avadel Pharmaceuticals PLCAVDL
+53.86%$6.35$9.77
2020-03-11 -
2021-03-12
Strong Buy
Prevail Therapeutics IncPRVL
+51.12%$15.22$23.00
2020-07-15 -
2021-01-21
Strong Buy
Pepgen IncPEPG
+41.02%$11.19$15.78
2022-05-30 -
2023-05-30
Strong Buy

Paul Matteis Analyst Color

Get additional color on Paul Matteis's coverage of popular stocks

Paul Matteis's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Lexeo Therapeutics IncLXEO
1Strong Buy$20.00+67.50%Initiates Coverage On
a day ago
Vertex Pharmaceuticals IncVRTX
12Hold$373.00+7.48%Reiterates
7 days ago
Vistagen Therapeutics IncVTGN
1Strong Buy$12.00+222.58%Initiates Coverage On
15 days ago
Neumora Therapeutics IncNMRA
1Strong Buy$26.00+115.23%Initiates Coverage On
2 months ago
Alnylam Pharmaceuticals IncALNY
6Strong Buy$240.00+48.74%Reiterates
2 months ago
Alector IncALEC
3Hold$8.00+55.04%Maintains
4 months ago
Sage Therapeutics IncSAGE
3Hold$22.00+14.17%Downgrades
4 months ago
Biomarin Pharmaceutical IncBMRN
4Strong Buy$108.00+23.06%Maintains
4 months ago
Biogen IncBIIB
5Strong Buy$320.00+40.72%Maintains
4 months ago
Pepgen IncPEPG
2Strong Buy$24.00+427.47%Reiterates
5 months ago
Alkermes PLCALKS
4Hold$33.00+40.13%Maintains
6 months ago
Neurocrine Biosciences IncNBIX
4Strong Buy$125.00+10.78%Maintains
6 months ago
Karuna Therapeutics IncKRTX
3Strong Buy$295.00N/AMaintains
a year ago
Cerevel Therapeutics Holdings IncCERE
2Strong Buy$54.00N/AMaintains
a year ago
Athira Pharma IncATHA
2Hold$5.00N/ADowngrades
a year ago
Kalvista Pharmaceuticals IncKALV
1Strong Buy$32.00N/AMaintains
a year ago
Vigil Neuroscience IncVIGL
1Strong Buy$24.00N/AInitiates Coverage On
2 years ago
Eliem Therapeutics IncELYM
1Strong Buy$35.00N/AInitiates Coverage On
2 years ago
Acumen Pharmaceuticals IncABOS
1Strong Buy$27.00N/AInitiates Coverage On
2 years ago
Gh Research PLCGHRS
1Strong Buy$26.00N/AInitiates Coverage On
2 years ago
Acadia Pharmaceuticals IncACAD
3Hold$27.00N/ADowngrades
3 years ago
Dyne Therapeutics IncDYN
1Strong Buy$29.00N/AInitiates Coverage On
3 years ago
Prevail Therapeutics IncPRVL
1Strong Buy$23.00N/AInitiates Coverage On
3 years ago
Gw Pharmaceuticals PLCGWPH
4Hold$140.00N/ADowngrades
3 years ago
Avadel Pharmaceuticals PLCAVDL
1Strong Buy$14.00N/AInitiates Coverage On
4 years ago
Denali Therapeutics IncDNLI
1Hold$26.00N/AInitiates Coverage On
4 years ago
Zogenix IncZGNX
3Buy$60.00N/AInitiates Coverage On
5 years ago
Acorda Therapeutics IncACOR
1Hold$2,280.00N/AMaintains
5 years ago
Ionis Pharmaceuticals IncIONS
2Hold$48.00N/AMaintains
5 years ago
Akcea Therapeutics IncAKCA
2Hold$31.00N/AMaintains
5 years ago
Obseva SaOBSVF
1Buy$18.00N/AMaintains
6 years ago
Wave Life Sciences LtdWVE
1Buy$64.00N/AMaintains
6 years ago
Cidara Therapeutics IncCDTX
1Buy$17.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.